ANGO vs NWS · rev $292.5M vs rev $9.03B
AngioDynamics Inc (ANGO) versus NWS (NWS) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
NWS (NWS) common stock.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported NWS revenue for 2026-06-30 was $9.03B. Net income was $573.0M. Revenue was up 6.8% from 2025-06-30 to 2026-06-30. NWS currently screens at market cap $0.
ANGO currently screens at market cap $378.5M. NWS currently screens at market cap $0.
Not investment advice. Open the ANGO and NWS stock pages for the full models.
Not investment advice.